Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NovoCure Ltd | 28,770 | reported | 06 Jan 2023 | tx 60+149,603−64,806 |
| Opus Genetics, Inc. | 4,750 | reported | 28 Feb 2019 | tx 12+2,696,302−2,375 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2023 | GRANT_AWARD | NovoCure Ltd | 98 | 62.31 USD | |
| 03 Aug 2022 | SALE | NovoCure Ltd | 563 | 71.09 USD | |
| 03 Aug 2022 | SALE | NovoCure Ltd | 5,396 | 74.00 USD | |
| 02 Aug 2022 | SALE | NovoCure Ltd | 437 | 69.66 USD | |
| 05 Jul 2022 | GRANT_AWARD | NovoCure Ltd | 222 | 59.08 USD | |
| 10 May 2022 | SALE | NovoCure Ltd | 2,070 | 65.16 USD | |
| 11 May 2022 | SALE | NovoCure Ltd | 2,135 | 61.25 USD | |
| 04 Mar 2022 | SALE | NovoCure Ltd | 1,510 | 70.41 USD | |
| 03 Mar 2022 | SALE | NovoCure Ltd | 803 | 74.50 USD | |
| 03 Mar 2022 | GRANT_AWARD | NovoCure Ltd | 17,371 | 0.00 USD | |
| 03 Mar 2022 | GRANT_AWARD | NovoCure Ltd | 5,452 | 80.59 USD | deriv |
| 03 Mar 2022 | GRANT_AWARD | NovoCure Ltd | 30,422 | 80.59 USD | deriv |
| 06 Jan 2022 | GRANT_AWARD | NovoCure Ltd | 55 | 63.82 USD | |
| 03 Aug 2021 | SALE | NovoCure Ltd | 464 | 150.11 USD | |
| 30 Jul 2021 | EXERCISE | NovoCure Ltd | 651 | 83.30 USD | |
| 30 Jul 2021 | SALE | NovoCure Ltd | 651 | 158.96 USD | |
| 02 Aug 2021 | SALE | NovoCure Ltd | 536 | 149.38 USD | |
| 30 Jul 2021 | EXERCISE | NovoCure Ltd | 651 | 0.00 USD | deriv |
| 06 Jul 2021 | GRANT_AWARD | NovoCure Ltd | 90 | 137.12 USD | |
| 27 May 2021 | EXERCISE | NovoCure Ltd | 1,833 | 47.56 USD | |
| 27 May 2021 | SALE | NovoCure Ltd | 1,833 | 200.00 USD | |
| 27 May 2021 | EXERCISE | NovoCure Ltd | 1,833 | 0.00 USD | deriv |
| 12 May 2021 | SALE | NovoCure Ltd | 1,943 | 180.48 USD | |
| 11 May 2021 | SALE | NovoCure Ltd | 2,262 | 180.12 USD | |
| 10 May 2021 | SALE | NovoCure Ltd | 1,833 | 189.65 USD |